VIR
Vir BiotechnologyCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
VIR vs peer average
43/100
VIR vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 2 · D 2
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
GILD is the first available peer comparator.
Gilead is not a size peer, but it is a useful directional comparator for liver-disease strategic value and commercialization context; the contrast mostly highlights how early-stage Vir still is rather than supporting a direct multiple comparison.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VIR
Vir Biotechnology
GILD
Gilead Sciences
Grade
C
C
Momentum
45
35
Value
41
65
Sentiment
67
58
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs GILD
VIR / GILD
Grade Position
Below peers
VIR vs. peer average (C vs. C)
43/100
Momentum
45
VIRValue
41
GILDSentiment
67
VIRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VIR
GILD is the first peer returned for this comparison set.